Clinical Trials Browser

Phase 1 × Unknown × Neoplasms by Histologic Type × Clear all

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Phase 1 Unknown

189 enrolled

Tumor-Agnostic

Neoplasms, Neoplasms by Histologic Type

NCT04309084 2023-02-16

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Phase 1 Unknown

29 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT03114670 2017-06-14

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT

Phase 1 Unknown

20 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Recurrence, Leukemia, Myeloid, Acute, Disease Attributes

Clinical Trials

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Donor-derived Anti-CD123-CART Cells for Recurred AML After Allo-HSCT